Today’s Hot List: Coherus Biosciences, Inc. (NASDAQ:CHRS), Conifer Holdings, Inc. (NASDAQ:CNFR), CNH Industrial N.V. (NYSE:CNHI), Healthstream Inc. (NASDAQ:HSTM),

Coherus Biosciences, Inc. (NASDAQ:CHRS) announced that it will present at the Cowen and Company 36th Annual Healthcare Conference on Tuesday, March 8 at 10:00 am ET in Boston, Massachusetts.

Coherus Biosciences, Inc. (NASDAQ:CHRS) belongs to Healthcare sector. Its weekly performance is -1.37%. On last trading day company shares ended up at $14.43. Coherus Biosciences, Inc. (NASDAQ:CHRS) distance from 50-day simple moving average (SMA50) is -13.61%.

On 22 February, Conifer Holdings, Inc. (NASDAQ:CNFR) announced results for the fourth quarter and full year 2015. Gross written premiums increased 11.8% for 2015 compared to 2014. Excluding the personal automobile and the Florida homeowners lines, gross written premiums increased by 21.6%.

Conifer Holdings, Inc. (NASDAQ:CNFR) shares decreased -3.82% in last trading session and ended the day at $6.04. CNFR return on assets is -3.30%. Conifer Holdings, Inc. (NASDAQ:CNFR) quarterly performance is -34.88%.

On 23 February, CNH Industrial N.V. (NYSE:CNHI) announces that under the common share buy-back program disclosed on January 29, 2016, the Company has purchased the common shares on the Italian Stock Exchange (M.T.A.).

On 26 February, CNH Industrial N.V. (NYSE:CNHI) shares moved up 0.77% and was closed at $6.51. CNHI EPS growth in last 5 year was -44.37%. CNH Industrial N.V. (NYSE:CNHI) year to date (YTD) performance is -4.82%.

On 16 February, Healthstream Inc. (NASDAQ:HSTM) announced results for the fourth quarter and full year ended December 31, 2015. Revenues of $55.9 million in the fourth quarter of 2015, up 23% from $45.3 million in the fourth quarter of 2014

Healthstream Inc. (NASDAQ:HSTM) ended the last trading day at $20.93. Company weekly volatility is calculated as 4.74%. Healthstream Inc. (NASDAQ:HSTM) showed a weekly performance of -0.71%.

Northfield Bancorp, Inc. (NASDAQ:NFBK) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday, Analyst Ratings.Net reports. The brokerage currently has a $17.00 price objective on the stock. Zacks Investment Research‘s target price points to a potential upside of 10.68% from the stock’s current price.

Northfield Bancorp, Inc. (NASDAQ:NFBK) shares moved up 0.06% in last trading session and ended the day at $15.67. NFBK return on assets is 0.60%. Northfield Bancorp, Inc. (NASDAQ:NFBK) quarterly performance is -0.61%.

Leave a Reply

Your email address will not be published. Required fields are marked *